High-impact radiopeptide therapy halts neuroendocrine cancer (EurekAlert, 6 June 2011)

07 Jun 2011


Research into neuroendocrine cancer from the University of Heidelberg, Germany, has been presented at the Society of Nuclear Medicine's 58th annual meeting.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story